2/9
08:17 am
cmnd
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
High
Report
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
2/6
07:55 am
cmnd
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
High
Report
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
2/3
08:00 am
cmnd
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
High
Report
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
1/20
06:21 pm
cmnd
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025 [Yahoo! Finance]
Low
Report
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025 [Yahoo! Finance]
1/20
04:20 pm
cmnd
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
Medium
Report
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
1/14
08:55 am
cmnd
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
Low
Report
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
12/31
09:10 am
cmnd
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
Low
Report
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/24
04:31 pm
cmnd
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth [Yahoo! Finance]
High
Report
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth [Yahoo! Finance]
12/24
09:15 am
cmnd
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth
Medium
Report
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth
12/20
01:30 am
cmnd
Clearmind Medicine (NASDAQ:CMND) was upgraded by analysts at
Wall Street
Low
Report
Clearmind Medicine (NASDAQ:CMND) was upgraded by analysts at
Wall Street
12/16
09:23 am
cmnd
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 [Yahoo! Finance]
Medium
Report
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 [Yahoo! Finance]
12/16
08:45 am
cmnd
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
Medium
Report
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
12/12
08:37 am
cmnd
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment [Yahoo! Finance]
Medium
Report
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment [Yahoo! Finance]
12/12
08:32 am
cmnd
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
Medium
Report
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
12/12
07:39 am
cmnd
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement [Yahoo! Finance]
Medium
Report
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement [Yahoo! Finance]
12/12
07:38 am
cmnd
Clearmind Medicine regains compliance with Nasdaq [Seeking Alpha]
Medium
Report
Clearmind Medicine regains compliance with Nasdaq [Seeking Alpha]
12/12
06:32 am
cmnd
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Medium
Report
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
12/10
04:46 pm
cmnd
Clearmind Medicine Announces 1-for-40 Reverse Share Split [Yahoo! Finance]
High
Report
Clearmind Medicine Announces 1-for-40 Reverse Share Split [Yahoo! Finance]
12/10
04:28 pm
cmnd
Clearmind Medicine to enact 1-for-40 reverse share split; shares down [Seeking Alpha]
High
Report
Clearmind Medicine to enact 1-for-40 reverse share split; shares down [Seeking Alpha]
12/10
04:15 pm
cmnd
Clearmind Medicine Announces 1-for-40 Reverse Share Split
High
Report
Clearmind Medicine Announces 1-for-40 Reverse Share Split
12/5
06:13 pm
cmnd
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification [Yahoo! Finance]
Low
Report
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification [Yahoo! Finance]
12/5
05:00 pm
cmnd
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Low
Report
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
12/2
07:57 am
cmnd
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
Low
Report
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
12/1
09:13 am
cmnd
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial [Yahoo! Finance]
Medium
Report
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial [Yahoo! Finance]
12/1
08:56 am
cmnd
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
Medium
Report
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial